Delaware House Bill HB169

Delaware 2025-2026 Regular Session

• Introduced: 5/15/25
• Introduced: 6/11/25
• Refer: 5/15/25
• Engrossed: 6/12/25
• Refer: 6/12/25
• Enrolled: 6/26/25
• Passed: 8/25/25

Caption

An Act To Amend Title 16 Of The Delaware Code Relating To The Behavioral Health Consortium And The Prescription Opioid Distribution Commission.

Impact

The bill proposes significant changes in how Delaware addresses the opioid crisis through legislative oversight. It mandates a coordinated effort to distribute settlement funds purely aimed at harm reduction and offers guidelines for utilizing these resources effectively. It also ensures that decisions on the distribution of these funds consider the experiences and perspectives of the affected communities, which is expected to lead to more informed and impactful initiatives related to substance use disorder treatment.

Summary

House Bill 169 aims to amend Title 16 of the Delaware Code, specifically regarding the Behavioral Health Consortium and the Prescription Opioid Distribution Commission. This legislation intends to expand the charge of the Behavioral Health Consortium to encompass all aspects of behavioral health care, alongside enhancing the roles of the Prescription Opioid Settlement Distribution Commission. The bill seeks to ensure that funds derived from opioid settlements are utilized to combat and mitigate the opioid crisis's impact within the state, which has seen a worrying increase in overdose deaths and addiction-related issues.

Sentiment

The sentiment surrounding HB 169 leans toward a positive reception among advocates for behavioral health reforms and substance use treatment. Lawmakers emphasize the importance of a comprehensive approach to address the ripple effects of the opioid crisis on families and communities. This bill is perceived as a proactive step toward strengthening the existing framework and increasing accountability in the distribution of settlement funds.

Contention

Notable points of contention may arise regarding the specific allocation of funds and the extent of authority granted to the newly structured commission. Critics may express concerns over the removal of previous oversight mechanisms that ensured non-profit representation in fund management. Additionally, discussions may center on the governance structure of the Behavioral Health Consortium and whether changes adequately reflect the needs of diverse community stakeholders involved in behavioral health services.